Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hepatitis
  Free Subscription

Articles published in
Dig Dis Sci
    April 2024
  1. PEARLMAN BL
    Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis.
    Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08393.
    >> Share

    February 2024
  2. CON D, Tu S, Clayton-Chubb D, Lubel JS, et al
    Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B.
    Dig Dis Sci. 2024 Feb 20. doi: 10.1007/s10620-024-08354.
    >> Share

  3. HUANG J, Cheng C, Li K, Zhu C, et al
    Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis.
    Dig Dis Sci. 2024 Feb 10. doi: 10.1007/s10620-023-08258.
    >> Share

    December 2023
  4. POOLA S, Kratzer M, Sewell K, Tillmann HL, et al
    Size Matters! Anti-HBs Titer and HBV Reactivation During Anti-TNF Therapy.
    Dig Dis Sci. 2023;68:4511-4520.
    >> Share

    November 2023
  5. SUN Y, Lu M, Feldman R, Saul M, et al
    Positive Predictive Value of Cirrhosis and Chronic Pancreatitis Diagnoses in Individuals with Alcohol Use Disorder: A Single-Center Study.
    Dig Dis Sci. 2023 Nov 29. doi: 10.1007/s10620-023-08183.
    >> Share

    October 2023
  6. JINDAL A, Sharma MK, Vijayaraghavan R, Sm S, et al
    Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2023 Oct 31. doi: 10.1007/s10620-023-08144.
    >> Share

  7. BUI HH, Nguyen ST, Phan ST, Nguyen KM, et al
    Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Oct 20. doi: 10.1007/s10620-023-08143.
    >> Share

  8. KILANI Y, Arshad I, Aldiabat M, Bhatija RR, et al
    Autoimmune Hepatitis and Obstetrical Outcomes: A Nationwide Assessment.
    Dig Dis Sci. 2023 Oct 10. doi: 10.1007/s10620-023-08129.
    >> Share

  9. EVON DM, Lin HS, Khalili M, Wahed AS, et al
    Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial.
    Dig Dis Sci. 2023 Oct 7. doi: 10.1007/s10620-023-08108.
    >> Share

    September 2023
  10. CZAJA AJ
    Introducing Molecular Chaperones into the Causality and Prospective Management of Autoimmune Hepatitis.
    Dig Dis Sci. 2023 Sep 27. doi: 10.1007/s10620-023-08118.
    >> Share

    August 2023
  11. PAN C, Gish R, Jacobson IM, Hu KQ, et al
    Correction to: Diagnosis and Management of Hepatitis Delta Virus Infection.
    Dig Dis Sci. 2023 Aug 10. doi: 10.1007/s10620-023-08046.
    >> Share

    July 2023
  12. MOHAMED MF, Wadhavkar N, Elfanagely Y, Marino D, et al
    Etiologies and Outcomes of Transaminase Elevation > 1000 IU/L: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2023;68:2843-2852.
    >> Share

  13. HSU CL, Wang Y, Duan Y, Chu H, et al
    Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.
    Dig Dis Sci. 2023;68:3059-3069.
    >> Share

    June 2023
  14. PAN C, Gish R, Jacobson IM, Hu KQ, et al
    Diagnosis and Management of Hepatitis Delta Virus Infection.
    Dig Dis Sci. 2023 Jun 20. doi: 10.1007/s10620-023-07960.
    >> Share

  15. KARIMI-SARI H, Falade-Nwulia O
    Hepatitis Delta Virus Infection in the United States: If You Seek, You May Find.
    Dig Dis Sci. 2023 Jun 14. doi: 10.1007/s10620-023-07961.
    >> Share

  16. MASOOD M, Siddique A, Kozarek RA
    Adult Hemophagocytic Lymphohistiocytosis Mimicking Acute Viral Hepatitis.
    Dig Dis Sci. 2023 Jun 8. doi: 10.1007/s10620-023-07985.
    >> Share

    May 2023
  17. CZAJA AJ
    Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis.
    Dig Dis Sci. 2023 May 9. doi: 10.1007/s10620-023-07967.
    >> Share

    April 2023
  18. RUSTAM LB, Vander Weg M, Chrischilles E, Tanaka T, et al
    Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
    Dig Dis Sci. 2023 Apr 27. doi: 10.1007/s10620-023-07951.
    >> Share

  19. WANG CL, Huang CH, Wu VC, Wu CL, et al
    Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C.
    Dig Dis Sci. 2023 Apr 18. doi: 10.1007/s10620-023-07943.
    >> Share

  20. MAJEED NA, Alawad AS, Liem KS, Takyar V, et al
    Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07916.
    >> Share

    February 2023
  21. BONKOVSKY HL, Rudnick SP, Ma CD, Overbey JR, et al
    Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.
    Dig Dis Sci. 2023 Feb 22. doi: 10.1007/s10620-023-07859.
    >> Share

  22. MA GX, Zhu L, Tan Y, Zhai S, et al
    A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus.
    Dig Dis Sci. 2023 Feb 7. doi: 10.1007/s10620-023-07840.
    >> Share

  23. MATEOS-MUNOZ B, Buti M, Vazquez IF, Conde MH, et al
    Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2023 Feb 3. doi: 10.1007/s10620-022-07817.
    >> Share

  24. CHIU SM, Chang KC, Hu TH, Hung CH, et al
    Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.
    Dig Dis Sci. 2023;68:665-675.
    >> Share

    December 2022
  25. XU J, Wang Y, Feng H, Liu F, et al
    HBV/HCV Infection Was Not Significantly Independently Associated with COVID-19 Severity: A Meta-Analysis of Confounding Variables-Adjusted Data.
    Dig Dis Sci. 2022 Dec 23:1-3. doi: 10.1007/s10620-022-07799.
    >> Share

  26. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
    Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
    >> Share

  27. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
    Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
    Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
    >> Share

    October 2022
  28. CZAJA AJ
    Missing Causality and Heritability of Autoimmune Hepatitis.
    Dig Dis Sci. 2022 Oct 19. pii: 10.1007/s10620-022-07728.
    >> Share

  29. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
    Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
    >> Share

  30. LIU CH, Jiang W, Wu DB, Zeng QM, et al
    Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Oct 13. pii: 10.1007/s10620-022-07695.
    >> Share

    September 2022
  31. HONMA Y, Shibata M, Morino K, Koya Y, et al
    Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.
    Dig Dis Sci. 2022 Sep 14. pii: 10.1007/s10620-022-07686.
    >> Share

  32. YU Y, Li X, Wan T
    Effects of Hepatitis B Virus Infection on Patients with COVID-19: A Meta-Analysis.
    Dig Dis Sci. 2022 Sep 9. pii: 10.1007/s10620-022-07687.
    >> Share

    July 2022
  33. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    >> Share

  34. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    >> Share

  35. FANG HW, Yen YH, Hung CH, Wang JH, et al
    Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir.
    Dig Dis Sci. 2022;67:3402-3411.
    >> Share

    June 2022
  36. BERNSTEIN DE, Trinh HN, Schiff ER, Smith CI, et al
    Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV.
    Dig Dis Sci. 2022;67:2637-2645.
    >> Share

    May 2022
  37. LLOYD C, Leighton J, Wong LL, Goulding A, et al
    Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.
    Dig Dis Sci. 2022 May 17. pii: 10.1007/s10620-022-07525.
    >> Share

  38. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    >> Share

  39. RAO A, Rule JA, Cerro-Chiang G, Stravitz RT, et al
    Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.
    Dig Dis Sci. 2022 May 11. pii: 10.1007/s10620-022-07524.
    >> Share

  40. SHROFF H, Fix OK
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: Real or Imagined?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07509.
    >> Share

    April 2022
  41. CHOW KW, Pham NV, Ibrahim BM, Hong K, et al
    Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature.
    Dig Dis Sci. 2022 Apr 29. pii: 10.1007/s10620-022-07504.
    >> Share

  42. JONES E, Watkins M, Anderson E, Gelow K, et al
    Overlooked Symptoms in Autoimmune Hepatitis Negatively Impact Many Facets of Life.
    Dig Dis Sci. 2022 Apr 19. pii: 10.1007/s10620-022-07484.
    >> Share

    March 2022
  43. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
    >> Share

  44. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    >> Share

  45. MAK LY, Wong DK, Cheung KS, Hui RW, et al
    Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus Infection.
    Dig Dis Sci. 2022 Mar 8. pii: 10.1007/s10620-022-07429.
    >> Share

  46. SAAB S, Pham N, Wu W, Dang L, et al
    Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naive Chronic Hepatitis B Patients.
    Dig Dis Sci. 2022 Mar 4. pii: 10.1007/s10620-022-07402.
    >> Share

    February 2022
  47. CZAJA AJ
    Advancing Biologic Therapy for Refractory Autoimmune Hepatitis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-021-07378.
    >> Share

    January 2022
  48. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    >> Share

    November 2021
  49. CHANG JI, Sinn DH, Cho H, Kim S, et al
    Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07312.
    >> Share

    September 2021
  50. CHUN HS, Lee JS, Lee HW, Kim BK, et al
    Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
    >> Share

    July 2021
  51. VAZ K, Little R, Majeed A, Kemp W, et al
    Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic Hepatitis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07140.
    >> Share

  52. TOKA B, Koksal AS, Eminler AT, Tozlu M, et al
    Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.
    Dig Dis Sci. 2021;66:2417-2426.
    >> Share

    June 2021
  53. GELOW K, Chalasani S, Green K, Lammert C, et al
    Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
    Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
    >> Share

    May 2021
  54. CHEN J, Hubbard A, Bagley L, Shiau R, et al
    Prevalence of Latent Tuberculosis Infection Among Persons with Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 May 30. pii: 10.1007/s10620-021-07056.
    >> Share

  55. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    >> Share

  56. LIN MH, Li HQ, Zhu L, Su HY, et al
    Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
    >> Share

  57. HE WQ, Matthews GV, Liu B
    Characteristics Associated with Monitoring and Treatment of Chronic Hepatitis B in a Large Cohort of Australian Adults.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-07008.
    >> Share

    April 2021
  58. LAMMERT C, Chalasani SN, Green K, Atkinson E, et al
    Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.
    Dig Dis Sci. 2021 Apr 30. pii: 10.1007/s10620-021-06989.
    >> Share

  59. CZAJA AJ
    Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis.
    Dig Dis Sci. 2021 Apr 9. pii: 10.1007/s10620-021-06968.
    >> Share

  60. CHANG PE, Tan CK, Cheah CC, Li W, et al
    Validation of the Expanded Baveno-VI Criteria for Screening Gastroscopy in Asian Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2021;66:1343-1348.
    >> Share

    February 2021
  61. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016